Literature DB >> 23406570

Measures such as interstate cooperation would improve the efficacy of programs to track controlled drug prescriptions.

Richard A Deyo1, Jessica M Irvine, Lisa M Millet, Todd Beran, Nicole O'Kane, Dagan A Wright, Dennis McCarty.   

Abstract

In response to increasing abuse of prescription drugs, forty-four states have implemented--and five more states will soon adopt--monitoring programs to track prescriptions of controlled medications. Although these programs were originally designed to help law enforcement officials and regulatory agencies spot possible illegal activity, health care providers have begun to use data from them to help improve patient safety and quality of care. For this article we reviewed government documents, expert white papers, articles from the peer-reviewed medical literature, and reports of the experiences of local health officials. We found some evidence that prescription drug monitoring programs are a benefit to both law enforcement and health care delivery. However, the programs have strengths and weaknesses, and their overall impact on drug abuse and illegal activity remains unclear. We believe that improving the efficacy of prescription drug monitoring programs will require such changes as more standardization and interstate cooperation, better training of providers, more secure funding, and further evaluation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23406570      PMCID: PMC3835343          DOI: 10.1377/hlthaff.2012.0945

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  29 in total

Review 1.  Maximizing the value of electronic prescription monitoring programs.

Authors:  David B Brushwood
Journal:  J Law Med Ethics       Date:  2003       Impact factor: 1.718

Review 2.  Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction.

Authors:  Bridget A Martell; Patrick G O'Connor; Robert D Kerns; William C Becker; Knashawn H Morales; Thomas R Kosten; David A Fiellin
Journal:  Ann Intern Med       Date:  2007-01-16       Impact factor: 25.391

3.  The influence of prescription monitoring programs on chronic pain management.

Authors:  Jing Wang; Paul J Christo
Journal:  Pain Physician       Date:  2009 May-Jun       Impact factor: 4.965

4.  Opioids for chronic pain.

Authors:  Deborah Grady; Seth A Berkowitz; Mitchell H Katz
Journal:  Arch Intern Med       Date:  2011-06-13

5.  Time series analysis of California's prescription monitoring program: impact on prescribing and multiple provider episodes.

Authors:  Aaron M Gilson; Scott M Fishman; Barth L Wilsey; Carlos Casamalhuapa; Hassan Baxi
Journal:  J Pain       Date:  2011-11-23       Impact factor: 5.820

6.  Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009.

Authors:  Stephen W Patrick; Robert E Schumacher; Brian D Benneyworth; Elizabeth E Krans; Jennifer M McAllister; Matthew M Davis
Journal:  JAMA       Date:  2012-04-30       Impact factor: 56.272

7.  Innovations: Alcohol & drug abuse: Narcotics on the net: the availability of Web sites selling controlled substances.

Authors:  Robert F Forman
Journal:  Psychiatr Serv       Date:  2006-01       Impact factor: 3.084

8.  Prescription drug monitoring programs and death rates from drug overdose.

Authors:  Leonard J Paulozzi; Edwin M Kilbourne; Hema A Desai
Journal:  Pain Med       Date:  2011-02-18       Impact factor: 3.750

9.  A long way to go: practice patterns and evidence in chronic low back pain care.

Authors:  Timothy S Carey; Janet K Freburger; George M Holmes; Liana Castel; Jane Darter; Robert Agans; William Kalsbeek; Anne Jackman
Journal:  Spine (Phila Pa 1976)       Date:  2009-04-01       Impact factor: 3.468

Review 10.  Oral or transdermal opioids for osteoarthritis of the knee or hip.

Authors:  Eveline Nüesch; Anne Ws Rutjes; Elaine Husni; Vivian Welch; Peter Jüni
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07
View more
  20 in total

1.  The use of a prescription drug monitoring program to develop algorithms to identify providers with unusual prescribing practices for controlled substances.

Authors:  Christopher Ringwalt; Sharon Schiro; Meghan Shanahan; Scott Proescholdbell; Harold Meder; Anna Austin; Nidhi Sachdeva
Journal:  J Prim Prev       Date:  2015-10

Review 2.  Opioids for low back pain.

Authors:  Richard A Deyo; Michael Von Korff; David Duhrkoop
Journal:  BMJ       Date:  2015-01-05

3.  Association Between Initial Opioid Prescribing Patterns and Subsequent Long-Term Use Among Opioid-Naïve Patients: A Statewide Retrospective Cohort Study.

Authors:  Richard A Deyo; Sara E Hallvik; Christi Hildebran; Miguel Marino; Eve Dexter; Jessica M Irvine; Nicole O'Kane; Joshua Van Otterloo; Dagan A Wright; Gillian Leichtling; Lisa M Millet
Journal:  J Gen Intern Med       Date:  2016-08-02       Impact factor: 5.128

4.  Shifting blame: Buprenorphine prescribers, addiction treatment, and prescription monitoring in middle-class America.

Authors:  Sonia Mendoza; Allyssa S Rivera-Cabrero; Helena Hansen
Journal:  Transcult Psychiatry       Date:  2016-08-03

5.  Clinicians' Use of Prescription Drug Monitoring Programs in Clinical Practice and Decision-Making.

Authors:  Gillian J Leichtling; Jessica M Irvine; Christi Hildebran; Deborah J Cohen; Sara E Hallvik; Richard A Deyo
Journal:  Pain Med       Date:  2017-06-01       Impact factor: 3.750

6.  Evolution and convergence of state laws governing controlled substance prescription monitoring programs, 1998-2011.

Authors:  Corey S Davis; Matthew Pierce; Nabarun Dasgupta
Journal:  Am J Public Health       Date:  2014-06-12       Impact factor: 9.308

7.  Leading a Horse to Water: Facilitating Registration and Use of a Prescription Drug Monitoring Program.

Authors:  Richard A Deyo; Jessica M Irvine; Sara E Hallvik; Christi Hildebran; Todd Beran; Lisa M Millet; Miguel Marino
Journal:  Clin J Pain       Date:  2015-09       Impact factor: 3.442

8.  Development and Feasibility of an Academic Detailing Intervention to Improve Prescription Drug Monitoring Program Use Among Physicians.

Authors:  Kelly S Barth; Sarah Ball; Rachel S Adams; Ruslan Nikitin; Nikki R Wooten; Zaina P Qureshi; Mary J Larson
Journal:  J Contin Educ Health Prof       Date:  2017       Impact factor: 1.355

9.  Oregon's strategy to confront prescription opioid misuse: a case study.

Authors:  Dennis McCarty; Rob Bovett; Thomas Burns; Judy Cushing; Mary Ellen Glynn; Senator Jeff Kruse; Lisa M Millet; Jim Shames
Journal:  J Subst Abuse Treat       Date:  2014-08-02

10.  Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-Related Death Rates.

Authors:  Stephen W Patrick; Carrie E Fry; Timothy F Jones; Melinda B Buntin
Journal:  Health Aff (Millwood)       Date:  2016-06-22       Impact factor: 6.301

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.